Turkish Journal of Biology
Abstract
Background/aim: Quercetin (Q) is a compound that can inhibit the growth of cancer cells in the colon; however, to do so, a high dose is needed, requiring a drug delivery system to target cancer endothelial cells directly. This study investigates the potency of nanodiamond-conjugated quercetin (NDQ) as an anticancer drug against colon cancer in Rattus norvegicus induced by N-methyl N-Nitrosourea (MNU). Materials and methods: This study is experimental-based and was designed using a six-group treatment method, namely normal control (KN: not treated by MNU, nanodiamond (ND), or Q); negative control (K–: treated by MNU); positive control (K+: treated by MNU and capecitabine); ND (treated by MNU and NDs); Q (treated by MNU and Q); and NDQ (treated by MNU and NDQ). To induce colon cancer in rats, MNU (10 mg/Kg BW) was administrated intrarectally three times per week for four weeks. The treatment of Q (40 mg/Kg BW) or NDQ (40 mg/Kg BW) was given intraperitoneally twice a week for 6 weeks. Cancer progression of all cohorts was evaluated by performing body and colon weight measurements, which involved the following: ELISA assay-specific to metastatic marker matrix metalloprotein-9 (MMP-9), carcinoembryonic antigen (CEA), hypoxia-inducible factor 1 α (HIF1α), vascular endothelial growth factor, protein 53 (p53) and immunohistochemistry staining of Caspase-3 and Ki-67 proteins. Observation of cancer metastasis to the lung was also performed. Results: NDQ significantly inhibited cancer aggressiveness by causing an increment in body weight gain and the growth rate—while reducing the colon weight compared to the K– group. Moreover, decreased levels of MMP-9, CEA, HIF-1α, and Ki67 and increased levels of p53 and Caspase-3 were more significant in the NDQ group than in the Q group. The lung tumor metastases in the NDQ group were fewer than in the K– group. Conclusion: NDQ increased Q’s anticancer activity, suggesting that NDs have an effective drug delivery property.
Author ORCID Identifier
FIRLI RAHMAH PRIMULA DEWI: 0000-0002-7813-8435
SEPHIA TIARA MARVIELLA: 0000-0003-2165-9851
SRI PUJI ASTUTI WAHYUNINGSIH: 0000-0003-1027-7110
A'LIYATUR ROSYIDAH: 0000-0001-8427-4364
VUANGHAO LIM: 0000-0001-5081-0982
LIONEL LIAN AUN IN: 0000-0001-7182-112X
AMY YI HSAN SAIK: 0000-0002-9831-4395
BIMAJI ARIYOGO: 0009-0003-6949-4766
MEE LEE LOOI: 0000-0001-5415-6973
DOI
10.55730/1300-0152.2704
Keywords
Anticancer, quercetin, nanodiamond, colon cancer, metastasis
First Page
279
Last Page
289
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
DEWI, FIRLI RAHMAH PRIMULA; MARVIELLA, SEPHIA TIARA; WAHYUNINGSIH, SRI PUJI ASTUTI; ROSYIDAH, A'LIYATUR; LIM, VUANGHAO; IN, LIONEL LIAN AUN; SAIK, AMY YI HSAN; ARIYOGO, BIMAJI; and LOOI, MEE LEE
(2024)
"Antimetastatic effect of nanodiamond-conjugated quercetin against colon cancer: an in vivo study,"
Turkish Journal of Biology: Vol. 48:
No.
5, Article 2.
https://doi.org/10.55730/1300-0152.2704
Available at:
https://journals.tubitak.gov.tr/biology/vol48/iss5/2